JANEL DUVAL: Open Payments
NPI 1790318079 · WHITE SETTLEMENT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 15 payments from 9 companies in 2025. Trend: 2023 $646 · 2024 $534 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| ABBVIE INC. | 2 | $41 |
| Lilly USA, LLC | 2 | $32 |
| Novo Nordisk Inc | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, VRAYLAR, MOUNJARO, FREESTYLE LIBRE, SHINGRIX, Veozah, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
